Godavari Drugs Ltd.Inverse H&S / C&H Formation: Yearly Basis
C&H Price Trendline BreakOut
Vol. Consolidation/BreakOut
*With Upside, Trail SL*
*Book Profit as per Risk Appetite*
*Snapshot*
Estab. in 1987, engaged in manufacturing of APIs
Revenue /Profit Stable on Qtrly/Yrly Basis. Gaining Traction.
Moderate Lev
5.60INR
37.86 MINR
1.60 BINR
About GODAVARI DRUGS LTD.
Sector
CEO
Mukund Kakani
Headquarters
Secunderabad
Website
Employees (FY)
104
Founded
1987
ISIN
INE362C01012
FIGI
BBG000F8F6B3
Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Ciprofloxacin Hydrochloride, Enrofloxacin, Centrizine Hydrochloride, Ethambutol Hydrochloride, A D Lactone, and Benzhyryl Piperazine. The company was founded on December 2, 1987 and is headquartered in Secunderabad, India.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GODAVARI is 101.40 INR — it has increased by 3.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GODAVARI DRUGS LTD. stocks are traded under the ticker GODAVARI.
GODAVARI DRUGS LTD. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track GODAVARI DRUGS LTD. financials in yearly and quarterly reports right on TradingView.
Like other stocks, GODAVARI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GODAVARI DRUGS LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 104.00 employees. See our rating of the largest employees — is GODAVARI DRUGS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GODAVARI DRUGS LTD. EBITDA is 115.13 M INR, and current EBITDA margin is 7.64%. See more stats in GODAVARI DRUGS LTD. financial statements.